These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20681478)

  • 41. Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.
    Falamarzian A; Aliabadi HM; Molavi O; Seubert JM; Lai R; Uludağ H; Lavasanifar A
    J Biomed Mater Res A; 2014 Sep; 102(9):3216-28. PubMed ID: 24167124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paclitaxel as first-line treatment for metastatic breast cancer. The Taxol Investigational Trials Group, Australia and New Zealand.
    Bishop JF; Dewar J; Toner GC; Tattersall MH; Olver IN; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J
    Oncology (Williston Park); 1997 Apr; 11(4 Suppl 3):19-23. PubMed ID: 9144686
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mining small-molecule screens to repurpose drugs.
    Swamidass SJ
    Brief Bioinform; 2011 Jul; 12(4):327-35. PubMed ID: 21715466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen.
    Perez Manga G; Madrigal Alonso P; Alburquerque Carbuccia H
    Cancer Chemother Pharmacol; 1982; 7(2-3):231-3. PubMed ID: 6896298
    [No Abstract]   [Full Text] [Related]  

  • 46. Reverse ethnopharmacology and drug discovery.
    Leonti M; Stafford GI; Cero MD; Cabras S; Castellanos ME; Casu L; Weckerle CS
    J Ethnopharmacol; 2017 Feb; 198():417-431. PubMed ID: 28063920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Benefit of the addition of paclitaxel to standard chemotherapy with 5-fluorouracil/doxorubicin/cyclophosphamide in patients with operable breast cancer.
    Clin Breast Cancer; 2000 Oct; 1(3):189-90. PubMed ID: 11899642
    [No Abstract]   [Full Text] [Related]  

  • 48. Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience.
    Singh JC; Mamtani A; Barrio A; Morrow M; Sugarman S; Jones LW; Yu AF; Argolo D; Smyth LM; Modi S; Schweber S; Boafo C; Patil S; Norton L; Baselga J; Hudis CA; Dang C
    Oncologist; 2017 Feb; 22(2):139-143. PubMed ID: 28167568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recurrent breast cancer treated successfully with mitomycin-C and vinblastine after failure of both doxorubicin-containing regimen and paclitaxel--a case report.
    Sekine I; Sasaki Y; Fujii H; Ohtsu T; Wakita H; Igarashi T; Itoh K; Abe K
    Tohoku J Exp Med; 1996 Mar; 178(3):331-7. PubMed ID: 8727715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro activity of taxol and taxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancers.
    Zoli W; Flamigni A; Frassineti GL; Bajorko P; De Paola F; Milandri C; Amadori D; Gasperi-Campani A
    Breast Cancer Res Treat; 1995 Apr; 34(1):63-9. PubMed ID: 7749161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An injectable, thermosensitive and multicompartment hydrogel for simultaneous encapsulation and independent release of a drug cocktail as an effective combination therapy platform.
    Wang W; Song H; Zhang J; Li P; Li C; Wang C; Kong D; Zhao Q
    J Control Release; 2015 Apr; 203():57-66. PubMed ID: 25683618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current status of paclitaxel in the treatment of breast cancer.
    O'Shaughnessy JA; Cowan KH
    Breast Cancer Res Treat; 1995; 33(1):27-37. PubMed ID: 7749130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Etoposide in the management of metastatic breast cancer.
    Sledge GW
    Cancer; 1991 Jan; 67(1 Suppl):266-70. PubMed ID: 1984826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mining connections between chemicals, proteins, and diseases extracted from Medline annotations.
    Baker NC; Hemminger BM
    J Biomed Inform; 2010 Aug; 43(4):510-9. PubMed ID: 20348023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality.
    Miksad RA; Abernethy AP
    Clin Pharmacol Ther; 2018 Feb; 103(2):202-205. PubMed ID: 29214638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of pigmentary side effects of taxanes and anthracyclines: an onychoscopic evaluation.
    Yorulmaz A; Dogan M; Artuz F; Zengin N
    Cutan Ocul Toxicol; 2017 Jun; 36(2):135-139. PubMed ID: 27086693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Compound Data Mining for Drug Discovery.
    Bajorath J
    Methods Mol Biol; 2017; 1526():247-256. PubMed ID: 27896746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network.
    Jadamba E; Shin M
    Biomed Res Int; 2016; 2016():7147039. PubMed ID: 28127549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Taxanes as adjuvant for breast cancer.
    Goldhirsch A; Francis P; Castiglione-Gertsch M; Gelber RD; Coates AS
    Lancet; 2000 Aug; 356(9228):507-8. PubMed ID: 10981914
    [No Abstract]   [Full Text] [Related]  

  • 60. Adaptive mining and model building of medicinal chemistry data with a multi-metric perspective.
    Brown JB
    Future Med Chem; 2018 Aug; 10(16):1885-1887. PubMed ID: 29966447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.